Showing results 973 to 992 of 993
< previous
next >
| Title | Author(s) | Issue Date | |
|---|---|---|---|
Vaccination with adeno-associated virus vector encoding severe acute respiratory syndrome coronavirus S protein induces potent and prolonged antibodies. Proceeding/Conference:European Congress of Clinical Microbiology & Infectious Diseases, ECCMID 2006 | 2006 | ||
Vaccine coverage of recent isolates of drug-resistant Streptococcus pneumoniae in Hong Kong Proceeding/Conference:Western Pacific Congress on Chemotherapy & Infectious Diseases, WPCCID-7 | 2000 | ||
Validation of the quickvue rapid diagnostic test for influenza in Hong Kong community Proceeding/Conference:HKCCM 2007 Annual Scientific Meeting | 2007 | ||
The validity of utilizing respiratory mortality data for identification of influenza epidemics in air pollution time-series studies Proceeding/Conference:Better Air Quality Workshop, BAQ 2004 | 2004 | ||
Variability of viral shedding dynamics among cases of influenza A virus infections Proceeding/Conference:HKCCM 2012 Annual Scientific Meeting | 2012 | ||
A variant in the CD209 promoter is associated with severity of Severe Acute Respiratory Syndrome (SARS) Proceeding/Conference:HUGO Annual Human Genome Meeting, HGM 2006 | 2006 | ||
Verocytotoxin-producing Escherichia coli infection: The Hong Kong experience Proceeding/Conference:Journal of Gastroenterology and Hepatology | 1998 | ||
Viral load and antibody response of COVID-19 patients Proceeding/Conference:COVID-19 Forum, Hospital Authority | 2020 | ||
Viral pneumonia: diagnosis and management Proceeding/Conference:Congress of Asian Pacific Society of Respirology | 2014 | ||
Viral suppression of type I interferon production through PACT targeting Proceeding/Conference:ICIS Satellite Symposium: Yin-Yang of the Interferon System | 2014 | ||
What have we learned from the Talaromyces marneffei genome so far? Proceeding/Conference:Medical Mycology Training Network (MMTN) Conference 2018 (Taipei, Taiwan) | 2018 | ||
Why COX inhibitors may help patients with influenza A/H5N1 virus infections Proceeding/Conference:Annual Meeting of the Infectious Diseases Society of America, IDSA 2009 | 2009 | ||
| 1997 | |||
Zika virus NS5 protein differentially modulates type I and type II interferon signaling Proceeding/Conference:Cross Street Immunology Conference, National Taiwan University, 2017 | 2017 | ||
Zika virus NS5 protein selectively activates type II interferon signaling in human glioblastoma cells. Proceeding/Conference:Cell Symposium on Neuro-Immune Axis: Reciprocal regulation in development, health, and disease | 2017 | ||
Zika virus NS5 protein suppresses type I and type III interferon signaling but augments type II interferon signaling Proceeding/Conference:American Society for Virology 36th Annual Meeting | 2017 | ||
Zika Virus:What Clinicians Should Know Proceeding/Conference:The 336th and 337th Hong Kong Doctors Union Sunday Afternoon Symposium | 2016 | ||
Δ42PD-1 expressed M2 macrophages promoted tumor recurrence after liver transplantation Proceeding/Conference:Transplantation | 2018 | ||
愛滋病免疫治癒研究: Bila-SG廣譜中和抗體研發進展 Proceeding/Conference:5th AIDS Forum of Beijing, Hong Kong and Macau and Taiwan | 2019 | ||
艾滋病抗体治疗 Proceeding/Conference:第二届'中国学者应对艾滋病难题大挑战'研讨会 | 2018 |